184 related articles for article (PubMed ID: 12904413)
1. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
Sergerie Y; Boivin G
J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drug susceptibility of human herpesvirus 8.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
[TBL] [Abstract][Full Text] [Related]
4. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Maggs DJ; Clarke HE
Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
[TBL] [Abstract][Full Text] [Related]
6. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
[TBL] [Abstract][Full Text] [Related]
9. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
[TBL] [Abstract][Full Text] [Related]
11. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
Baldanti F; Biron KK; Gerna G
J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475
[No Abstract] [Full Text] [Related]
12. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
[No Abstract] [Full Text] [Related]
14. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
[TBL] [Abstract][Full Text] [Related]
16. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of porcine cytomegalovirus to antiviral drugs.
Fryer JF; Griffiths PD; Emery VC; Clark DA
J Antimicrob Chemother; 2004 Jun; 53(6):975-80. PubMed ID: 15117919
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]